Ranitidine inhibition of breast tumor growth is B cell dependent and associated with an enhanced antitumor antibody response

Dakota Rogers, Ava Vila-Leahey, Ana Clara Pessôa, Sharon Oldford, Paola A. Marignani, Jean S. Marshall

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)
Original languageEnglish
Article number1894
JournalFrontiers in Immunology
Volume9
Issue numberAUG
DOIs
Publication statusPublished - Aug 15 2018
Externally publishedYes

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Immunology

Keywords

  • Breast cancer
  • Histamine receptor
  • Immunology
  • Myeloid-derived suppressor cells
  • Natural killer cells

Fingerprint

Dive into the research topics of 'Ranitidine inhibition of breast tumor growth is B cell dependent and associated with an enhanced antitumor antibody response'. Together they form a unique fingerprint.

Cite this

Rogers, D., Vila-Leahey, A., Pessôa, A. C., Oldford, S., Marignani, P. A., & Marshall, J. S. (2018). Ranitidine inhibition of breast tumor growth is B cell dependent and associated with an enhanced antitumor antibody response. Frontiers in Immunology, 9(AUG), Article 1894. https://doi.org/10.3389/fimmu.2018.01894